Acute hepatitis C: A multifaceted disease

被引:54
作者
Heller, T [1 ]
Rehermann, B [1 ]
机构
[1] NIDDK, Liver Dis Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA
关键词
acute; liver; hepatitis C virus; treatment; interferon; T cell; immune response;
D O I
10.1055/s-2005-864778
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although acute hepatitis C virus (HCV) infection is a rare disease and typically not associated with severe clinical symptoms, it has become a disease of significant interest for clinical investigators, virologists, and immunologists alike. In the same way that acute hepatitis C provided a window of opportunity for understanding the clinical and virological aspects of HCV infection as the field was being established, it is now clear that it can provide a window into further understanding the early interaction of the virus with the host immune response. The acute phase of infection is usually considered to be the first 6 months; however, rather than defining acute HCV by the time that has passed after initial infection, it can also be defined as the biological state in which spontaneous clearance is still possible.
引用
收藏
页码:7 / 17
页数:11
相关论文
共 90 条
[1]
Natural recovery from acute hepatitis C virus infection by agammaglobulinemic twin children [J].
Adams, G ;
Kuntz, S ;
Rabalais, G ;
Bratcher, D ;
Tamburro, CH ;
Kotwal, GJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (05) :533-534
[2]
Natural history of hepatitis C [J].
Alberti, A ;
Chemello, L ;
Benvegnù, L .
JOURNAL OF HEPATOLOGY, 1999, 31 :17-24
[3]
Therapy of acute hepatitis C [J].
Alberti, A ;
Boccato, S ;
Vario, A ;
Benvegnú, L .
HEPATOLOGY, 2002, 36 (05) :S195-S200
[4]
Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection [J].
Allen, TM ;
Altfeld, M ;
Yu, XG ;
O'Sullivan, KM ;
Lichterfeld, M ;
Le Gall, S ;
John, M ;
Mothe, BR ;
Lee, PK ;
Kalife, ET ;
Cohen, DE ;
Freedberg, KA ;
Strick, DA ;
Johnston, MN ;
Sette, A ;
Rosenberg, ES ;
Mallal, SA ;
Goulder, PJR ;
Brander, C ;
Walker, BD .
JOURNAL OF VIROLOGY, 2004, 78 (13) :7069-7078
[5]
DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS IN PROSPECTIVELY FOLLOWED TRANSFUSION RECIPIENTS WITH ACUTE AND CHRONIC NON-A-HEPATITIS, NON-B-HEPATITIS [J].
ALTER, HJ ;
PURCELL, RH ;
SHIH, JW ;
MELPOLDER, JC ;
HOUGHTON, M ;
CHOO, QL ;
KUO, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1494-1500
[6]
RISK-FACTORS FOR ACUTE NON-A, NON-B HEPATITIS IN THE UNITED-STATES AND ASSOCIATION WITH HEPATITIS-C VIRUS-INFECTION [J].
ALTER, MJ ;
HADLER, SC ;
JUDSON, FN ;
MARES, A ;
ALEXANDER, WJ ;
HU, PY ;
MILLER, JK ;
MOYER, LA ;
FIELDS, HA ;
BRADLEY, DW ;
MARGOLIS, HS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (17) :2231-2235
[7]
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections [J].
Appay, V ;
Dunbar, PR ;
Callan, M ;
Klenerman, P ;
Gillespie, GMA ;
Papagno, L ;
Ogg, GS ;
King, A ;
Lechner, F ;
Spina, CA ;
Little, S ;
Havlir, DV ;
Richman, DD ;
Gruener, N ;
Pape, G ;
Waters, A ;
Easterbrook, P ;
Salio, M ;
Cerundolo, V ;
McMichael, AJ ;
Rowland-Jones, SL .
NATURE MEDICINE, 2002, 8 (04) :379-385
[8]
A FADD-dependent innate immune mechanism in mammalian cells [J].
Balachandran, Siddharth ;
Thomas, Emmanuel ;
Barber, Glen N. .
Nature, 2004, 432 (7015) :401-405
[9]
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes [J].
Bartosch, B ;
Dubuisson, J ;
Cosset, FL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) :633-642
[10]
Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C [J].
Baumert, TF ;
Wellnitz, S ;
Aono, S ;
Satoi, J ;
Herion, D ;
Gerlach, JT ;
Pape, GR ;
Lau, JYN ;
Hoofnagle, JH ;
Blum, HE ;
Liang, TJ .
HEPATOLOGY, 2000, 32 (03) :610-617